Cilo Cybin expects full-year loss per share of 95.88-96.05 cents on IFRS 2 listing expense
Reuters2026/08/12 15:30- Cilo Cybin flagged a sharp swing to a full-year loss, driven by an IFRS 2 listing expense of ZAR 217.48 million.
- EPS is expected at a loss of 95.88 to 96.05 cents, versus a reported loss of 0.85 cents a year earlier.
- HEPS is expected at a loss of 95.88 to 96.05 cents, versus a reported loss of 0.85 cents previously.
- Prior-year EPS and HEPS will be restated to 9.49 cents under reverse acquisition accounting tied to the CC Pharmaceutical deal.
- Annual results are expected on or about Aug. 28, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBS lowers Ciena target price to $394
EUR/USD Price Forecast: Holds key 100-day SMA at start of the US CPI week
Malaysia Govt Spending Plan Could Help 99 Speed Mart Retail -- Market Talk
Paying the price for supporting the yen? Japan's foreign reserves fell by $87.8 billions in August, possibly due to selling US Treasuries for funding.
Japanese authorities may have used part of their foreign exchange reserves, including foreign securities such as U.S. Treasury bonds, over the past month to fund record-sized foreign exchange intervention operations.
Crypto prices
More
